Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study
Patients initiating SITT in Germany had significantly higher adherence and persistence compared with patients initiating MITT over 6 to 18 months following treatment initiation. Among SITT, FF/UMEC/VI users had the highest proportion of adherence and persistence.
Authors
- Kai Michael Beeh (ORCID: https://orcid.org/0000-0001-9067-118X)
- Jing Claussen (ORCID: https://orcid.org/0000-0002-8703-0020)
- Chris Compton (ORCID: https://orcid.org/0000-0002-7564-5343)
- Michael Schultze (ORCID: https://orcid.org/0009-0002-1494-5446)
- Lena Richter (ORCID: https://orcid.org/0009-0007-0996-3005)
- Claus Franz Vogelmeier (ORCID: https://orcid.org/0000-0002-9798-2527)
- Afisi Ismaila (ORCID: https://orcid.org/0000-0002-2876-8308)
- Gema Requena (ORCID: https://orcid.org/0000-0002-1889-6656)
- Nils Kossack (ORCID: https://orcid.org/0000-0002-9521-3898)
- Stephen G. Noorduyn (ORCID: https://orcid.org/0000-0002-5936-5579)
Institutions
- Respiratory Research Institute (DE)
- German Center for Lung Research (DE)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- GlaxoSmithKline (Germany) (DE)
- IGES Institut (DE)
- Impact (CA)
- Berlin Center for Epidemiology and Health Research (DE)
- McMaster University (CA)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/copd.s460903
- Citations
- 12
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 5.03